-
-
BRUKINSA
- QTY 60
- 160 MG
- Tablet
- Near 77381
ZANUBRUTINIB (ZAN ue BROO ti nib) treats leukemia and lymphoma. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Change Location
Set Price Drop Alert for:
BRUKINSA
- QTY 60
- 160 MG
- Tablet
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
BRUKINSA
- QTY 60
- 160 MG
- Tablet
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Change Form
Medicine Chest
BRUKINSA Lifestyle Interactions
-
Zanubrutinib 160mg, Oral tablet
• Interaction: Grapefruit juice• Severity: Major• Notes for Consumers: Do not take Grapefruit juice or grapefruit-containing foods and Zanubrutinib together without talking to your health care provider. Side effects may get worse if you drink Grapefruit juice or consume grapefruit-containing foods while taking Zanubrutinib. Contact your prescriber immediately if you experience fever or chills, cough, sore throat, pain or trouble passing urine, unusual bleeding or bruising, chest pain, dizziness, fast or irregular heartbeat, palpitations, feeling faint or lightheaded, or breathing problems.• Notes for Professionals: Advise patients to avoid grapefruit juice or grapefruit-containing foods while taking zanubrutinib. Coadministration may result in increased zanubrutinib exposure and toxicity (e.g., infection, bleeding, and atrial arrhythmias). Zanubrutinib is a CYP3A4 substrate; grapefruit juice is a strong CYP3A4 inhibitor. The AUC of zanubrutinib was increased by 278% when coadministered with another strong CYP3A4 inhibitor.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
